https://rss.com/podcasts/rethinking-weight-loss-glp-1-meds I explore the growing impact of GLP-1 medications on weight management and overall health. Once developed to help manage type 2 diabetes, medications such as Ozempic, Wegovy, and Mounjaro have transformed conversations about obesity and weight loss. I'll discuss how these medications work in the body, why they help regulate appetite and blood sugar, and what current research reveals about their effectiveness. I'll also examine common misconceptions, potential side effects, and the broader implications for public health. Join me as I take a closer look at the science behind GLP-1 medications and how they are changing the future of weight loss treatment.

]]> RSS.com 2026.721.95756 Thu, 13 Aug 2026 21:19:44 GMT en caba2e3e-6022-5c92-b6c7-5e25218c7fe6 https://media.rss.com/rethinking-weight-loss-glp-1-meds/podcast_cover_20260625_080643_1d0fc0554bdba13b23f60387bb226a40.png https://rss.com/podcasts/rethinking-weight-loss-glp-1-meds no M. Perez M. Perez false episodic podcast false In this episode, I explore the growing impact of GLP-1 medications on weight management and overall health. Once developed to help manage type 2 diabetes, medications such as Ozempic, Wegovy, and Mounjaro have transformed conversations about obesity and weight loss. I'll discuss how these medications work in the body, why they help regulate appetite and blood sugar, and what current research reveals about their effectiveness. I'll also examine common misconceptions, potential side effects, and the broader implications for public health. Join me as I take a closer look at the science behind GLP-1 medications and how they are changing the future of weight loss treatment.

]]> https://rss.com/podcasts/rethinking-weight-loss-glp-1-meds/2943719 6e09c447-f11e-465c-bac5-36d465010bb0 411 full Thu, 13 Aug 2026 21:13:19 GMT false false